Your browser doesn't support javascript.
loading
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
Naranbhai, Vivek; Pernat, Claire A; Gavralidis, Alexander; St Denis, Kerri J; Lam, Evan C; Spring, Laura M; Isakoff, Steven J; Farmer, Jocelyn R; Zubiri, Leyre; Hobbs, Gabriela S; How, Joan; Brunner, Andrew M; Fathi, Amir T; Peterson, Jennifer L; Sakhi, Mustafa; Hambelton, Grace; Denault, Elyssa N; Mortensen, Lindsey J; Perriello, Lailoo A; Bruno, Marissa N; Bertaux, Brittany Y; Lawless, Aleigha R; Jackson, Monica A; Niehoff, Elizabeth; Barabell, Caroline; Nambu, Christian N; Nakajima, Erika; Reinicke, Trenton; Bowes, Cynthia; Berrios-Mairena, Cristhian J; Ofoman, Onosereme; Kirkpatrick, Grace E; Thierauf, Julia C; Reynolds, Kerry; Willers, Henning; Beltran, Wilfredo-Garcia; Dighe, Anand S; Saff, Rebecca; Blumenthal, Kimberly; Sullivan, Ryan J; Chen, Yi-Bin; Kim, Arthur; Bardia, Aditya; Balazs, Alejandro B; Iafrate, A John; Gainor, Justin F.
Afiliación
  • Naranbhai V; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Pernat CA; Dana-Farber Cancer Institute, Boston, MA.
  • Gavralidis A; Center for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • St Denis KJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Lam EC; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Spring LM; Salem Hospital, Salem, MA.
  • Isakoff SJ; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.
  • Farmer JR; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.
  • Zubiri L; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Hobbs GS; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • How J; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Brunner AM; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Fathi AT; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Peterson JL; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Sakhi M; Division of Hematology, Brigham and Women's Hospital, Boston, MA.
  • Hambelton G; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Denault EN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Mortensen LJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Perriello LA; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Bruno MN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Bertaux BY; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Lawless AR; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Jackson MA; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Niehoff E; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Barabell C; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Nambu CN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Nakajima E; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Reinicke T; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Bowes C; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Berrios-Mairena CJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Ofoman O; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Kirkpatrick GE; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Thierauf JC; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.
  • Reynolds K; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Willers H; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Beltran WG; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Dighe AS; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Saff R; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Blumenthal K; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.
  • Sullivan RJ; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.
  • Chen YB; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Kim A; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Bardia A; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Balazs AB; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Iafrate AJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Gainor JF; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
J Clin Oncol ; 40(1): 12-23, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34752147
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Marruecos